China NMPA approves Antengene’ IND application for phase Ib/II study of ATG-022 in combo with Keytruda± chemotherapy: Shanghai Wednesday, December 3, 2025, 18:00 Hrs [IST] Ante ...
Citius Oncology launches US FDA approved Lymphir, a novel cancer immunotherapy for cutaneous T-cell lymphoma: Cranford, New Jersey Wednesday, December 3, 2025, 16:00 Hrs [IST] Cit ...
Lenacapavir approved in Zambia and Zimbabwe in record time through WHO Collaborative Registration Procedure: Geneva Wednesday, December 3, 2025, 17:00 Hrs [IST] The Zambia Medicin ...
Bayer initiates phase III study SUNFLOWER with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia: Berlin Wednesday, December 3, 2025, ...
GSK plc will present new data from its haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition (6 - 9 December), reinforcing its potential to redefine ...
WHO issues global guideline on the use of GLP-1 medicines in treating obesity: Geneva Wednesday, December 3, 2025, 14:00 Hrs [IST] To address the growing global health challenge o ...
Exporters to strengthen supply chain independence as MSMEs struggle to meet revised Schedule M deadline: Shardul Nautiyal, Mumbai Wednesday, December 3, 2025, 08:00 Hrs [IST] Even ...
KSRPA urges govt to establish a dedicated veterinary drug cell within state FDA: Nandita Vijayasimha, Bengaluru Wednesday, December 3, 2025, 08:00 Hrs [IST] The Karnataka State Re ...
Despite lingering cash flow strains for MSMEs, pharma exporters have reported gradual recovery amidst depreciation of local currencies in Africa supported by RBI's rupee trade mechanisms. Exporters ...
CDSCO releases risk classification for 119 radiotherapy devices: Gireesh Babu, New Delhi Wednesday, December 3, 2025, 08:00 Hrs [IST] The Central Drugs Standard Control Organisati ...
Expert calls for complete overhaul of India’s health education regulatory system: Peethaambaran Kunnathoor, Chennai Wednesday, December 3, 2025, 08:00 Hrs [IST] A high-impact po ...
Roche gets US FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough: Basel Wednesday, December ...